Evidence map›Paper›PMID 26511990›Full record

SynthesisVirologica Sinica2015

The preventive effect of vaccine prophylaxis on severe respiratory syncytial virus infection: A meta-analysis.

Tongna Zhu, Chuanlong Zhang, Li Yu, Jingxian Chen, Huan Qiu, Weiwei Lyu, Shenghai Huang

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Virologica Sinica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Efficacy and safety of respiratory syncytial virus vaccines.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Observational
  3. Lower respiratory tract infection in the community: associations between viral aetiology and illness course.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Tongna ZhuDepartment of Microbiology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.
Chuanlong ZhangDepartment of Pediatrics, the People's Hospital of Lu'an City, Lu'an, 237005, China.
Li YuDepartment of Microbiology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.
Jingxian ChenDepartment of Microbiology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.
Huan QiuDepartment of Microbiology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.
Weiwei LyuDepartment of Microbiology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.
Shenghai HuangDepartment of Microbiology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China. shenghaihuang1@gmail.com.
Anhui Medical University · CNColumbia University · USLu'an First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is the key underlying cause of acute lower respiratory tract infection in infants; however, no licensed vaccine against RSV infection is currently available. This study was undertaken to assess the preventive effect of vaccine on RSV infection. In this metaanalysis, 1,792 published randomized clinical trials of RSV vaccines from Jan 1973 to Sep 2015 were examined. Among thirteen studies that met the inclusion criteria, eleven studies estimated the impact of RSV vaccines and four studies estimated the effect of adjuvants. The odds ratios (ORs) were 0.31 (95% CI, 0.15-0.67) and 0.62 (95% CI, 0.29-1.34), respectively. We found that RSV subunit vaccines can significantly reduce the incidence of RSV infection and that whether vaccination with adjuvant therapy was an effective strategy still remained to be studied. This analysis of the preventive effect of vaccines on RSV infection has direct applications for the prevention of RSV infections.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolHumansInfantOdds RatioRandomized Controlled Trials as TopicRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesYoung AdultRespiratory Syncytial Virus Vaccinesmeta-analysisrespiratory syncytial virus (RSV)vaccine prophylaxis

Identifiers

PMID26511990
PMCPMC8200922
OpenAlexW1866511557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.